Related Experiment Videos

Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study,

Lloyd E Chambless1, Aaron R Folsom, Vicki Davis

  • 1Department of Biostatistics, School of Public Health, University of North Carolina, Chapel Hill, NC 27514-4145, USA. wchambless@unc.edu

Insights

Established coronary heart disease risk factors, such as diabetes and smoking, are linked to the progression of subclinical atherosclerosis, measured by intima-media thickness changes.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Atherosclerosis Research
  • Public Health

Background:

  • Intima-media thickness (IMT) of common carotid arteries serves as a key biomarker for atherosclerosis.
  • IMT is significantly associated with prevalent and incident coronary heart disease (CHD) and its risk factors.

Purpose of the Study:

  • To investigate the association between baseline and changing cardiovascular risk factors and the progression of subclinical atherosclerosis.
  • To analyze changes in intima-media thickness (IMT) in relation to established CHD risk factors over time.

Main Methods:

  • Utilized data from the Atherosclerosis Risk in Communities (ARIC) study, a population-based cohort (n=15,792, ages 45-64 at baseline).
  • Assessed changes in IMT from 1987-1998 in relation to baseline and changing risk factors, with and without adjustment for baseline IMT and measurement error.
  • Examined associations with baseline risk factors (diabetes, smoking, HDL cholesterol, pulse pressure, WBC count, fibrinogen) and changes in risk factors (LDL cholesterol, triglycerides, onset of diabetes, hypertension).

Main Results:

  • Statistically significant associations were observed between changes in IMT and baseline diabetes, current smoking, high-density lipoprotein cholesterol, pulse pressure, white blood cell count, and fibrinogen.
  • Significant associations were also found between changes in IMT and changes in low-density lipoprotein cholesterol, triglycerides, and the onset of diabetes and hypertension.
  • The magnitude of these associations aligned with previous cross-sectional findings.

Conclusions:

  • Established coronary heart disease risk factors are demonstrably associated with the rate of progression of subclinical atherosclerosis.
  • Changes in IMT reflect the impact of both existing and developing risk factors over time.
  • This study reinforces the importance of managing cardiovascular risk factors to mitigate atherosclerosis progression.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...